Experimental research about the treatment for postoperative pathological changes : control of endothelial activation using antisense adenovirus vector

反义腺病毒载体控制内皮细胞活化治疗术后病变的实验研究

基本信息

  • 批准号:
    08671385
  • 负责人:
  • 金额:
    $ 1.41万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1996
  • 资助国家:
    日本
  • 起止时间:
    1996 至 1997
  • 项目状态:
    已结题

项目摘要

Activated vascular endothelial cells (ECs) produce various factors to contribute to the development of postoperative pathological changes. In this study, we investigated whether antisense adenovirus vector sgsist ICAM-1 mRNA could suppress ICAM-1 expression on activated ECs.DNAs complementary to ICAM-1, VCAM-1, E-selectin, and PDGF-A chain mRNAs were produced by RT/PCR of total cellular RNA from TNF-_<alpha> activated human umbilical vein ECs using respective sense and antisense primers. cDNAs were subcloned in plasmids and checked their sequences. Checked cDNAs were reversely ligated into the specific cosmids for generation of adenovirus vector. Antisense adenovirus vectors against ICAM-1, VCAM-1, and E-selection mRNAs was generated in 293 cells, resulting from the homologous recombination between cDNAs-reversely-ligated cosmids and adenovirus DNA.The adenovirus vectors were transfected into ECs and their transcripts were checked by RT/PCR.ICAM-1 pression was analyzed by cell-ELISA on lipopolysaccharide-activated ECs which was tranfected with antisense adenovirus vector against ICAM-1 mRNA.However, ICAM-1 expression inbuced by lipopolysaccharide could not be reduced by transfection of the antisense adenovirus vector. We considered that the reasons why the vector failed to reduced the ICAM-1 expression might be due the fact that the expression cassette of the vector included a short cDNA sequence as 143bp and a long mismatchcd sequence as 200bp. Moreover, we have experienced another failure of antisense adenovirus vector. Antisense adenovirus vector against insulin failed to reduce insulin secretion from the ECs transfected with insulin adenovirus vector. Since the vector contained 334 bp-reversed cDNA and 200bp-mismatched sequence, it is suggested that mismatched sequence may really inhibit the binding of antisense mRNA to sense mRNA or that antisense treatment may not be so effective as it has been reported.
活化的血管内皮细胞(ECs)产生多种因素促进术后病理改变的发展。在本研究中,我们研究了反义腺病毒载体sgsist ICAM-1 mRNA是否能抑制ICAM-1在活化的内皮细胞上的表达。利用TNF-_< α >激活的人脐静脉内皮细胞,分别用正义和反义引物对细胞总RNA进行RT/PCR,得到与ICAM-1、VCAM-1、E-selectin和PDGF-A链mrna互补的dna。在质粒中亚克隆cdna并检查其序列。将检查过的cdna反向连接到特定的细胞中,以产生腺病毒载体。在293细胞中,通过反向连接的cdna与腺病毒DNA的同源重组,生成了针对ICAM-1、VCAM-1和e -选择mrna的反义腺病毒载体。将腺病毒载体转染到ECs中,RT/PCR检测其转录产物。用细胞酶联免疫吸附法(elisa)分析脂多糖激活的内皮细胞对ICAM-1 mRNA的表达。然而,转染反义腺病毒载体不能降低脂多糖诱导的ICAM-1表达。我们认为,载体未能降低ICAM-1表达的原因可能是载体的表达盒中含有143bp的短cDNA序列和200bp的长mismatchcd序列。此外,我们还经历了另一次反义腺病毒载体的失败。抗胰岛素的反义腺病毒载体不能减少转染胰岛素腺病毒载体的内皮细胞的胰岛素分泌。由于载体含有334个bp反向的cDNA和200个bp错配序列,因此我们认为错配序列可能确实抑制了反义mRNA与义mRNA的结合,或者反义治疗可能不像报道的那样有效。

项目成果

期刊论文数量(23)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Yamaguchi M,et al.: "Heparin-like glycosaminoglycans inhibit leukocyte adhesion to endotoxin-activated human vascular endothelial cells under nonstatic conditions." Eur Surg Res. 28. 428-435 (1996)
Yamaguchi M 等人:“类肝素糖胺聚糖在非静态条件下抑制白细胞与内毒素激活的人血管内皮细胞的粘附。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yamaguchi M, et al.: "Dextran sulfate inhibited neutrophil adhesion to endotoxin-activated vascular endothelial cells via E-selectin-mediated cell adhesion under nonstatic conditions." J. Endotoxin Res.3. 21- (1996)
Yamaguchi M 等人:“硫酸葡聚糖在非静态条件下通过 E-选择素介导的细胞粘附抑制中性粒细胞与内毒素激活的血管内皮细胞的粘附。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yamaguchi M,et al.: "Selective inhibition of vascular cell adhesion molecule-1 expression in human vascular endothelial cells." Transplantation. 63. 759-764 (1997)
Yamaguchi M 等人:“选择性抑制人血管内皮细胞中血管细胞粘附分子-1 的表达。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yamaguchi M,et al.: "Insulin gene transfer compensated pancreatic beta cell function in diabetic rats." Transpl.Proc.(in press). (1997)
Yamaguchi M 等人:“胰岛素基因转移补偿了糖尿病大鼠的胰腺 β 细胞功能。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yamaguchi M, et al.: "Insulin gene transfer compensated pancreatic β cell function in diabetic rats." Transpl.Proc.(in press).
Yamaguchi M 等人:“胰岛素基因转移补偿了糖尿病大鼠的胰腺 β 细胞功能。”Transpl.Proc.(正在出版)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YAMAGUCHI Masahiko其他文献

YAMAGUCHI Masahiko的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YAMAGUCHI Masahiko', 18)}}的其他基金

Catalytic control of Belousov-Zhabotinsky oscillation reaction and related systems
Belousov-Zhabotinsky振荡反应及相关系统的催化控制
  • 批准号:
    25670001
  • 财政年份:
    2013
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Development of chiral cyanine dyes containing distorted π-planes
含有扭曲π平面的手性花青染料的开发
  • 批准号:
    24659001
  • 财政年份:
    2012
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Development and Efficient Production of Organosulfur and Organophosphorus Compounds by Transition Metal Catalyzed Method
过渡金属催化法开发及高效生产有机硫和有机磷化合物
  • 批准号:
    21229001
  • 财政年份:
    2009
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (S)
Organoheteroatom Chemistry Based on Transition Metal Catalysis
基于过渡金属催化的有机杂原子化学
  • 批准号:
    16109001
  • 财政年份:
    2004
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (S)
Research on treatments after maasive bowel resection : Effects of IGF-1 gene transfer
大肠切除术后的治疗研究:IGF-1 基因转移的影响
  • 批准号:
    15591436
  • 财政年份:
    2003
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Transition Metal Catalyzed Addition Reactions of Heteroatom Elements
过渡金属催化杂原子元素的加成反应
  • 批准号:
    14207094
  • 财政年份:
    2002
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Development of Efficient Vinylation and Ethynylation Reactions
高效乙烯基化和乙炔化反应的发展
  • 批准号:
    13557193
  • 财政年份:
    2001
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Experimental study for reconstruction of portal vein and inferior vena cava in liver surgery
肝脏手术中门静脉及下腔静脉重建的实验研究
  • 批准号:
    13671343
  • 财政年份:
    2001
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Chemistry of Optically Active Helicenes
光学活性螺旋烯的化学
  • 批准号:
    11470466
  • 财政年份:
    1999
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
Research on gene transfer of hepatocyte growth factor in hepato-spleno-surgery
肝细胞生长因子基因转移在肝脾外科中的研究
  • 批准号:
    11671273
  • 财政年份:
    1999
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Clinical application of boron-conjugated adenovirus vector for neutron capture therapy
硼缀合腺病毒载体中子捕获治疗的临床应用
  • 批准号:
    19K09482
  • 财政年份:
    2019
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Vascular-targeted gene therapy to block proliferation of smooth muscle cells using a novel adenovirus vector
使用新型腺病毒载体进行血管靶向基因治疗以阻止平滑肌细胞增殖
  • 批准号:
    2273599
  • 财政年份:
    2019
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Studentship
Gene therapy for diabetes mellitus based on the suppression of lipotoxicity using an improved adenovirus vector
使用改进的腺病毒载体抑制脂毒性的糖尿病基因治疗
  • 批准号:
    18K14964
  • 财政年份:
    2018
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Mechanisms of induction of mucosal immunity by adenovirus vector vaccine
腺病毒载体疫苗诱导粘膜免疫的机制
  • 批准号:
    16K18873
  • 财政年份:
    2016
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Hemophilia B Gene Therapy via CRISPR/Cas9-Targeted Integration of the Factor IX Gene using Adenovirus Vector Delivery
使用腺病毒载体递送通过 CRISPR/Cas9 靶向整合因子 IX 基因进行 B 型血友病基因治疗
  • 批准号:
    9193681
  • 财政年份:
    2016
  • 资助金额:
    $ 1.41万
  • 项目类别:
Gene therapy for diabetes mellitus and gene function analysis using a novel adenovirus vector
使用新型腺病毒载体进行糖尿病基因治疗和基因功能分析
  • 批准号:
    15K18939
  • 财政年份:
    2015
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Innate immue response through glycolipids by adenovirus-vector
腺病毒载体通过糖脂产生先天免疫反应
  • 批准号:
    26450450
  • 财政年份:
    2014
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of a novel method for highly efficient gene targeting by adenovirus vector on human naive pluripotent stem cells
开发一种通过腺病毒载体高效基因靶向人类幼稚多能干细胞的新方法
  • 批准号:
    26893253
  • 财政年份:
    2014
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Development of targeting adenovirus vector as boron carrier for boron neutron capture therapy
开发靶向腺病毒载体作为硼中子捕获疗法的硼载体
  • 批准号:
    26462183
  • 财政年份:
    2014
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of adenovirus vector lacking VA RNA genes for efficient microRNA expression
开发缺乏 VA RNA 基因的腺病毒载体以实现有效的 microRNA 表达
  • 批准号:
    24701021
  • 财政年份:
    2012
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了